Search Results

REALM IDx, Inc., a health care company pioneering the field of integrated diagnostics, announced that GenMineTOP Cancer Genome Profiling System has been awarded national health coverage in Japan and will begin full commercial launch of contract testing with strategic partner, LSI Medicine Corporation.

REALM IDx announced the launch of REALM Pharma Services, an end-to-end discovery, translational research, and clinical trial service for biotechnology and pharmaceutical partners.

Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging, has acquired Cell IDx, Inc., a leader in multiplexed tissue profiling.

Ambry Genetics, a prominent leader in clinical genomic testing and a subsidiary of REALM IDx, Inc., along with PacBio, a leading developer of high-quality, highly accurate sequencing solutions, announced their companies’ selection by the University of California, Irvine and the GREGoR Consortium to support the Pediatric Mendelian Genomics Research Center program to better understand the underlying biology of rare diseases.

REALM IDx, Inc., a leader in integrated diagnostics, announced the company will participate in the upcoming 40th Annual J.P. Morgan Health Care Conference.

Digital Diagnostics, a leading artificial intelligence (AI) diagnostic healthcare company’s flagship product, LumineticsCore™ (formerly IDx-DR), is increasing access to innovative care at OSF HealthCare for people living with diabetes.

Konica Minolta Precision Medicine (KMPM), a majority-owned subsidiary of Konica Minolta, Inc., announced today that it has changed its name to REALM IDx, Inc.